Transdermal oestradiol (tE2) patches as androgen deprivation therapy (ADT): efficacy and safety of combining with androgen receptor pathway inhibitors (ARPIs) in metastatic (M1) prostate cancer-randomised comparison from the STAMPEDE trial platform
James, N. D. ; Rush, H. ; Nankivell, M. G. ; Sehjal, J. ; Mangar, S. A. ; McPhail, N. ; Brown, S. ; Tanguay, J. S. ; Gale, J. ; Mohamed, W. ... show 10 more
James, N. D.
Rush, H.
Nankivell, M. G.
Sehjal, J.
Mangar, S. A.
McPhail, N.
Brown, S.
Tanguay, J. S.
Gale, J.
Mohamed, W.
Abstract
Description
Date
2025
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
James ND, Rush H, Nankivell MG, Sehjal J, Mangar SA, McPhail N, et al. Transdermal oestradiol (tE2) patches as androgen deprivation therapy (ADT): Efficacy and safety of combining with androgen receptor pathway inhibitors (ARPIs) in metastatic (M1) prostate cancer-Randomised comparison from the STAMPEDE trial platform. JOURNAL OF CLINICAL ONCOLOGY. 2025 FEB 10;43(5_SUPPL). PubMed PMID: WOS:001454740300025. English.